SK pharmteco

We were honored to participate in The Emerging Growth Health Care/Life Sciences Forum organized by The Main Line Chamber of Commerce this week, bringing together leaders from the life sciences sector. Our CEO, Joerg Ahlgrimm, delivered an insightful presentation on SK pharmteco, the current state of the market, and emerging industry trends. The event featured a thought-provoking Q&A session, providing a platform for engaging discussions in addition the opportunity to network over breakfast and coffee. We are grateful for the chance to connect with fellow leaders and share our vision for the future of life sciences. Thank you to the The Main Line Chamber of Commerce for organizing such an impactful gathering! #LifeSciences #Networking #CDMO

With the rapid rise of cellular and molecular medicines, the demand for innovative analytical methods is increasing. In a recent Contract Pharma article, Dana Cipriano, M.S., our Global Head of Analytical Services, explores how SK pharmteco is meeting these challenges head-on through our process development and manufacturing operations. We combine versatility, cutting-edge equipment, deep expertise, and a focus on emerging regulations to deliver unique, comprehensive solutions to help companies deliver life-changing therapies. Learn more about how SK pharmteco is leading the way in this dynamic market: https://lnkd.in/gbFiHfjd #CDMO #APIs #AnalyticalServices

HPLC method development is essential for accurately separating, identifying, and quantifying components in complex mixtures. This process is integral to ensure the purity, potency, and safety of pharmaceutical products. At SK pharmteco, our commitment to excellence drives us to develop robust and reliable HPLC methods that ensure the highest quality in pharmaceutical analysis. Leveraging our expertise in HPLC, we support nitrosamine analysis (with detection limits as low as 1 ppb), as well as chiral separations to separate enantiomers. Our CGMP laboratories have been successfully audited by the FDA and uphold the highest standards of quality. Our stringent approach enables us to deliver reliable and high-quality analytical results, ensuring the safety and efficacy of your products. We are dedicated to pushing the boundaries of pharmaceutical analysis to meet the highest industry standards. Want to learn more about what we're doing to ensure the safety of our client's products? Be sure to connect with Marc J Jacob, Ph.D. at #HPLC24 this week through 7/25 in Denver, CO! Marc will be on the floor discussing our cutting-edge technologies and how we can help enhance your analytical capabilities. See you in Denver! Contact us to learn more: https://lnkd.in/egVykeW7 #ActivePharmeceuticalIngredients #AnalytcalServices #HPLC

SK pharmteco had the honor of welcoming Congresswoman Mary Gay Scanlon this week. We are deeply grateful for her steadfast support of healthcare-related issues, including her co-sponsorship and advocacy for various bills aimed at enhancing healthcare access and fostering innovation. Her visit to our King of Prussia site, where we develop, manufacture, and test cutting-edge gene and cell therapies, was truly appreciated. We also extend our thanks to Life Sciences Pennsylvania for helping to arrange this visit. We look forward to her continued support in our mission to advance healthcare solutions. Avi Nandi and Audrey Greenberg gave a fantastic tour and overview of our Philadelphia Cell and Gene Therapy site. Also, thanks to Evan M. Schlaich for his wonderful explanation of techniques used to optimize priduction in process development before transfer to GMP production.

🎉 10K Followers! 🎉 We have reached 10,000 followers! 🌟 Thank you to our incredible community for helping SK pharmteco reach this milestone. Your support drives our commitment to innovation and excellence in the pharmaceutical industry. Here’s to many more milestones together! 🚀 #SKpharmteco #10KFollowers #Innovation

We were delighted to host the leadership team from AstraZeneca at our Small Molecule manufacturing facility in Swords, Dublin, Ireland. SK pharmteco is committed to advancing our capabilities, expanding capacities, and fostering productive partnerships. We look forward to supporting AstraZeneca in their mission to transform the future of healthcare by unlocking the power of what science can do for people, society, and the planet.   #Partnerships #ManufacturingExcellence #PharmaceuticalIndustry #smallmolecules #cdmo #pharmamanufacturing #activepharmaceuticalingredient

Yesterday, we joined our friends and colleagues in France in celebrating Bastille Day. This day marks the historic storming of the Bastille in 1789, a pivotal moment in the French Revolution that symbolizes the fight for freedom and equality. At SK pharmteco, we are proud to embrace these values as we collaborate globally to innovate and improve lives through our cutting-edge pharmaceutical solutions. Our team all around the world exemplifies the spirit of dedication and excellence that Bastille Day represents. #BastilleDay #FêteNationale #GlobalCollaboration

Adeno-associated virus (AAV) vectors are revolutionizing gene therapy, offering a highly precise and safe method for delivering life-changing therapies. However, ensuring the safety of these vectors in clinical applications is paramount. One significant challenge in biomanufacturing is the potential formation of replication-competent AAVs (rcAAVs), which pose safety risks. At SK pharmteco, we are at the forefront of addressing this challenge. Our rapid quantitative PCR (qPCR) assay, a cutting-edge cell-based technology, is designed to monitor the emergence of rcAAVs efficiently. Alongside this, we've developed innovative technologies to mitigate the risk of rcAAV formation, ensuring the highest safety standards. Our comprehensive approach supports gene therapy manufacturers by: 🔶 Sustaining High-Throughput Operations: Our technologies streamline biomanufacturing processes, enhancing productivity. 🔶Improving Quality Control: With precise monitoring, we ensure consistent and reliable quality in every batch. 🔶Enhancing Safety and Efficacy: By mitigating rcAAV risks, we help deliver safer and more effective gene therapies to patients. Read more about how we are transforming gene therapy manufacturing in this recent article with Genetic Engineering & Biotechnology News: https://lnkd.in/enYCpPdH

🌟 Meet Us at HPLC 2024! 🌟 Attending #HPLC2024 in Denver, CO July 20-25? Be sure to connect with Marc J Jacob, Ph.D. to discuss the latest advancements in liquid phase separations and related innovations. With decades of experience in manufacturing challenging chemistries, SK pharmteco has capabilities that support a wide range of processes and technologies. Whether you're interested in innovative separation techniques, cutting-edge technologies, or enhancing your analytical capabilities, we are here to help you find the perfect solutions. Can't wait to chat? Contact us to discover our capabilities: #ActivePharmaceuticalIngredients #AnalyticalServices #Chromatography

We are thrilled to announce that SK pharmteco's Audrey Greenberg will be speaking at Phacilitate Women in Advanced Therapies Global virtual event on July 10-11. Tune in tomorrow at 2 PM EDT to hear Audrey's valuable insights during the session, "Trailblazing Women in Biotech: Insights from Successful Female Founders & CEOs." WIAT Global is a digital event offering 24 hours of exclusive content tailored for industry leaders and innovators in the life sciences. This groundbreaking event brings together empowering women and their allies at the forefront of biotech, pharmaceuticals, and academia to drive progress in advanced therapies. Register for the event and explore the full agenda here: https://lnkd.in/eg9BW2eb #WIAT2024 #LifeSciences #WomenInLeadership #AdvancedTherapies #CGT #WomenInSTEM #Biotech #Pharmaceuticals #Innovation